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Introduction
Sudden rupture of a lipid-rich atherosclerotic plaque, caus
ing acute myocardial infarction is one of the major causes of 
death worldwide. Early detection of such coronary plaques 
may influence treatment strategies and facilitate a reduction 
in clinical events secondary to ischemic heart disease [1]. 
The lipid core plaque (LCP) or fibroatheroma is a type of 
atherosclerotic lesion prone to develop unstable features 
under the influence of inflammatory processes and mechan-
ical forces. Hence, imaging of tissue composition, espe-
cially in LCP, plays an important role in recognizing plaque 
instability [2]. LCP detection also has implications in the 
guidance of coronary interventions, as these plaques have 
been implicated in peri-procedural and follow-up events 
[3–8]. Intravascular optical coherence tomography (OCT) 
is now widely used as a clinical tool, imaging vessel lumen 
and wall morphology for guidance of stent placement and 
optimization [9–12]. OCT is a catheter-based imaging tech-
nique that provides high-resolution images of the arterial 
wall. Interpretation of the images allows for a qualitative 
assessment of the tissue composition [7,11, 12].
M asurement of lipid length and lipid arc in OCT for cal-
culation of a lipid score is a common method to quantify 
lipid in cardiovascular research [13, 14]. This scor  is an 
indicator of the extent and severity of atherosclerotic dis-
ease in the coronary arteries. It provides patient and lesion-
specific diagnostic information, and may serve as a metric of 
plaque progression in temporal studies. Currently a skilled 
OCT reader is required to score lipid accumulations, and 
it is a time-consuming manual procedure with considerable 
Abstract Lipid-core atherosclerotic plaques are associ-
ated with disease progression, proce ural complications, 
and cardiac events. Coronary plaque lipid can be quanti-
fied in optical coherence tomography (OCT) pullbacks by 
measurement of lipid arcs a d lipid le gths; parameters 
frequently used in clinical research, but labor intensive 
and subjective to analyse. In this study, we investigated the 
ability of quantitative attenu tion, derived from intravascu-
lar OCT, to detect plaque lipid. Lipid cores are associated 
with a high attenuation coefficient. We compared the index 
of plaque attenuation (IPA), a local quantitative measure of 
attenuation, to the manually measur d lipid score (arc and 
length) on OCT images, and to the plaque characterizati  
ex-vivo. We confirmed a correlation between the IPA and 
lipid scores (r2 > 0.7). Comparison to histo ogy shows that
high attenuation is associated with fibroatheroma, but also 
with macrophage presence. IPA is a robus , reproducible, 
and user-independent measure that facilitates quantification 
of coronary lipid, a potential tool in clinical research and in 
guiding percutaneous coronary i er ention.
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Histology and plaque characterization
The imaged vessels were pressure-fixed while still on the heart 
with buffered formalin at 100 mmHg for 15 min, excised from 
the heart, and fixed with buffered formalin for 24 h. Then the 
vessels were embedded in paraffin and cut into 4-mm blocks 
with the end of the guide catheter serving as a reference. The 
proximal face of each block was cut at 3 µm thickness for 
histological analysis and serial sections stained with Haema-
toxylin and Eosin (H&E), Elastic Van Gieson (EVG), Cluster 
of Differentiation 68 (CD68) and smooth muscle cell α-actin 
stains. CD68 and α-actin were visualized using mouse anti-
CD68 (DAKO M0814 and M0876 mixed 1/200 of each), 
and mouse anti-α actin (DAKO, M0851 1/200), or matched 
mouse IgG control, followed by biotinylated goat anti-mouse 
and extravidin-HRP conjugate with DAB staining.
Twenty-three atherosclerotic plaques were identified 
from the six cadaveric heart specimens. A skilled patholo-
gist analysed the plaque characteristics by the histological 
staining and classified the plaque type. The lesions were 
classified into pathological intimal thickening, pathological 
intimal thickening with macrophage infiltration and fibro-
atheroma using standard criteria [2, 22]. Fibroatherom
with less than 65 μm cap thickness was classified as thin-
cap fibroatheroma.
Parametric imaging
The acquired OCT images were analysed to quantify the 
attenuation coefficient of the tissues by fitting the OCT sig-
nal to a single scattering model [18, 19].
 (1)
where S(r) is the OCT signal roll off and T(r) is the point 
spread function (PSF) of the catheter [23]. The attenuation 
coefficient µt is the parameter of interest. The attenuation cal-
culation and the model implementation were done in Matlab 
release 2012b (The Mathworks, Inc., Natick, MA, USA). The 
model is fitted in the polar image, in every A-line starting 
from the edge of the lumen [18, 20], in small windows of 
varying length [24] to extract the attenuation coefficients. The 
accuracy of the extracted attenuation coefficient is approxi-
mately 1 mm−1 [8]. The data analysis results in an attenua-
tion image per frame of the pullback. Figure 1 depicts a frame 
of OCT, its corresponding attenuation image and histology.
We made longitudinal attenuation maps of the vessel 
depicting the tissue properties of the intima along the entire 
pullback. The map was constructed by sampling the maxi-
mum value of attenuation between the lumen border and the 
internal elastic lamina (IEL) as shown in Fig. 2. The en-face 
map display has dimensions of frame number (horizontal-
axis), rotational angle (vertical-axis) and color-codes the 
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inter-observer variability [13]. An automated tissue sco e 
that can provide the same information can be a very useful 
tool in research with potent al for clinical utility.
Various tissue components have di ferent optical para-
eters and this contrast can be exploit  to devise a tissue 
characterization method based on IV-OCT d ta [15]. Quan-
tification of tissue optical parameters may assist image 
interpretation by OCT users. The attenuation coefficient is a 
robust tissue optical parameter [16] that h s been proposed 
for tissue characterization [17–19]. Lipid-r ch necrotic ore 
and macrophage infiltration have high attenuation compared 
to fibrous tissue and other plaque components. Such meth-
ods have recently been augmented with statistical image 
metrics to achieve tissue detection [20].
In this study, we validate optical a tenuation imag-
ing of coronary plaque tissue type in a  ex-vivo setting,
using whole heart specimens harv s ed from cadavers and 
imaged in a purpose-built setup. We focus on the ability 
of attenuation imaging to identify coronary plaque lipid. 
The objective of the study w s to compare th  qua titative 
attenuation scores with the manually measur d lipid scores 
of plaque segments, which were characte ized based on the 
histology.
Materials and methods
Specimens
Whole cadaveric hearts used were obtained from the Bris-
tol Heart Valve Bank and excised within 48 h pos -mortem 
and stored at 4 °C [21]. Hearts were randomly selected from 
suitable specimens; meaning the major conduit coronary 
arteries needed to be intact. A short guide catheter was intro-
duced into the right coronary arte y to facilitate intravascu-
lar imaging and fixed in position with sutures. All tissues 
were handled in accordance with he local ethics regulations. 
The heart specimen was held within a custom-built Persp x 
container, with adapters on both sides of the lid allowing 
connection of the guide internally, and a Y-con ec or and 
pressure/injector manifold externally [21]. For the study a 
total of six heart specimens were imaged.
IV-OCT imaging
For intravascular OCT imaging, the imaged artery was per-
fused with phosphate buffered sa ine (PBS) a d the intra-
coronary pressure was maintained at 100 mmHg. The OCT 
image pullbacks of the coronary rteries were performed at 
20 mm/s. The OCT system used for i aging was a C7-XR 
with Dragonfly catheter (St. Jude Medical Inc. St. Paul, 
MN, USA).The end of the guide catheter served as a refer-
ence point.
1 3
3Int J Cardiovasc Imaging
to the total number of pixels, multiplied by a factor of 1000. 
Mathematically it is represented as
 (2)
where N is the number of pixels. x is the threshold in attenu-
ation coefficient, with a maximum value of 12 mm−1, that 
enables IPA to represent a particular tissue type.
IPA
N x
Nx
t
total
=
>
×
( )µ
1000
maximum attenuation coefficient per A-line in the range 
0–12 mm−1. Such a map highlights strongly ttenuating fea-
tures like the lipid plaques in the entire pullback [16] and 
corresponds well with a visual assessment of LCP in the 
OCT data by an expert reader [25].
We also defined an Index of Plaque Attenuation (IPA) to 
quantify the parametric imag . IPA is the ratio of th  num-
ber of pixels in the attenu tion map or a segment of it with 
an attenuation coefficient greater than a certain threshold x 
Fig. 2 A representative image 
of the en-face map depicting the 
attenuation features across the 
vessel and the 4 mm segment of 
a plaque that would be used to 
calculate the IPA. The inset plot
shows the IPA for the segment 
for different thresholds ‘x’ in 
IPAx. Color scale runs from 0 to 
12 mm−1
 
Fig. 1 A representative OCT 
frame and the corresponding 
attenuation image depicting 
high attenuation features and 
the corresponding histology 
stains. The arrow heads point 
to a streak of macrophages that 
shows high attenuation and are 
clearly stained in CD68. The 
dashed scale bar equals 1 mm
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The maximum correlation coefficient between the lipid 
score and IPAx was found for a threshold of x = 8.5 mm−1 
(IPA8.5), and equalled r = 0.85 (p < 0.0001). The relation-
ship between IPA and the lipid scores for all the 23 plaques 
are given in Fig. 3. The data points in the graph are color-
coded based on the plaque type classification as shown in 
the legend.
Discussion
This study investigated the ability of the index of plaque 
attenuation (IPA), a bias free and reproducible summary 
measurement of attenuating tissue types, to detect lipids. 
The study aimed to validate OCT attenuation coefficient as a 
lipid-core detection tool. The main finding of the study was 
that the OCT-derived index, the IPA8.5, have a significant 
correlation (r2 > 0.7) with the manual lipid score in OCT 
images, which enables automation of the coronary plaque 
lipid assessment by OCT. Lipid scoring is a time consuming 
process, where frame-by-frame analysis and measurement 
is required. Previous studies which compared the lipid score 
by OCT to automated indices like the near-infrared spec-
troscopy (NIRS)-based Lipid Core Burden Index (LCBI) 
found a lesser correlation (r2 = 0.436) [27]. This weaker 
association between OCT measurements and LCBI may 
be explained by registration errors in measurements made 
by different catheters, but also by the physically different 
detection mechanisms (scattering-dominated attenuation for 
OCT, vs. optical absorption in NIRS). The IPA, which is the 
result of automatic computation of plaque attenuation, has 
the potential as a clinical tool as it can indicate the presence 
and location of lipid rich plaques in an entire pullback, and 
provides an alternative to manual scoring in cardiovascu-
lar research. IPA could be displayed as a color-coded block 
along the vessel indicating probable lipid core plaques as 
shown in Fig. 4. IPA, being an index calculated from a phys-
ical parameter, is robust and reproducible.
Figure 3 demonstrated that thick cap fibroatheroma exhib-
ited a range of low to high IPA values, showing that lipid 
content is just one tissue component contributing to optical 
attenuation. We only found one thin cap fibroatheroma in our 
data, which had large OCT-lipid burden as expected [14]. It 
had a high IPA value, illustrating the relation between man-
ual OCT measurements and automatic IPA analysis. Its typi-
cal dense macrophage infiltration by histology contributed to 
the observed attenuation. Among the four plaques classified 
as pathological intimal thickening (PIT), two had macro-
phage infiltration. The two PITs with macrophage exhibited 
high IPA values even though pathological evidence of lipid 
was not available. The gap between the PITs with and with-
out macrophages was very significant, as expected. The three 
fibrotic plaques had near zero IPA values, as expected. The 
The IPA was calculated in 4 mm windows, c vering a 
plaque segment. For the frame pitch of 200 µm that we used 
in our study, a window for IPA computation comp ises 20 
OCT frames. The OCT data were matched to the histology 
cross-sections based on longitudinal position and general 
anatomy (side branches and pres nce of plaque).
Lipid measurements
Lipid measurements were made on the OCT frames, using 
the Ilumien offline OCT review workstation by St. Jude 
Medical (St. Paul, MN, USA). The lipid length was me-
sured by detection of sequen ial OCT frames within a plaque 
segment containing lipid, defined as a diffusely bordered 
signal-poor region with hig att nu tion by th  signal rich 
region covering them [7, 26]. The pitch of the OCT nabled
calculation of the lipid length in mm. The lipid arc measure-
ments were made by defining the circumferential extent of 
the lipid core from the vessel centre [14] and a me n for the 
plaque segment was calculated. Combining both measure-
ments a lipid score was calculated, ich is the product of 
the average lipid arc of the segment and the lipid length of 
the segment. To establish the relation be ween OCT lipid 
score and optical attenuation coefficient, we computed the 
correlation (Pearson’s r) between lipid score and IPAx for 
different values of x (1, 1.5, …, 12) in all segments.
Statistical analysis
Continuous variables are expressed as mean (standard 
deviation), or median (inte quar ile range; IQR) and cate-
gorical variables are expressed as percentages. The regres-
sion analysis was performed on the lipid measurements 
and IPA, with linear least squares fit and the coefficient 
of determination r2 (square of the correlation coefficient 
r) was used.
Results
According to the analysis of th  histological sections, ther  
were 16 fibroatheromas, 3 fibrous plaques, 2 pathological 
intimal thickenings and 2 p hological intimal th cken-
ings with macrophage infiltration. One fibroatheroma 
with <65 microns cap thickness was classified as thin cap 
fibroatheroma.
We measured the lipid scores in the OCT recordings of 
the segments of interest. The median f the mean lipid arc 
of the plaques was 81.98 ± 45 degrees and t e median f 
the lipid length was 3.9 ± 2.1 mm. The scores ranged from 
0 to 638.4 mm °. There were eight plaques that did not have 
the characteristics of LCP according to the cons nsus OCT 
criteria [7].
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by remapping the attenuation analysis to coordinates rela-
tive to the lumen center. The attenuation calculation itself is 
automated and fast but in calculation of IPA, manual media 
segmentation is currently necessary to avoid artefacts due to 
the intima-media border. To be able to automate the whole 
process and for application to large datasets, automated 
media segmentation is required. This software is currently 
under development in our institute [30].
Conclusion
We validated the optical attenuation coefficient, as mea-
sured by OCT, as a tissue classification tool in atheroscle-
rotic plaques. We investigated a quantitative measure of 
the attenuating tissue types, the index of plaque attenua-
tion (IPA). Our results show that the OCT-derived IPA8.5, 
quantifying the fraction of vessel wall with a maximum 
µt > 8.5 mm−1, has a correlation (r2 > 0.7) wi h the conven-
tional lipid score on OCT images. The results highlight the 
potential of a robust and fast identification tool of lipids in 
OCT pullbacks.
three fibrous plaques and the four PITs were among the eight 
plaques scored as having no lipid on OCT, along with on  
fibroatheroma with deep extra-cellular cholesterol.
Limitations
Our data set is targeted towards validation f lipid measure-
ments, and so does not reflect the heterogeneity of athero-
sclerosis in a clinical setting, with few plaques other than 
FA, and only one TCFA. The two included macrophage-
infiltrated PIT plaques exhibit high attenuation even in the 
absence of histological evidence for lipids, a known mecha-
nism resulting in false positiv s for lip d detection by OCT 
[7, 28, 29]. It was not possible to compare IPA with the lipid 
scores from histology as it s not practic l to measure lipid 
length and the mean lipid arc in the whole segment. The IPA 
is effectively an area measure, which can be affected by the 
position of the catheter relative to the centre of the lumen, 
as is the LCBI based on NIRS. For s all to mode ately 
sized vessels, the difference is smaller than the sc tter in 
the data we observe in Fig. 3. We did not apply a correction 
in this analysis, although it would be possible in principle 
Fig. 3 Correlation between 
IPA8.5 and lipid score by OCT 
(the product of mean lipid arc 
and lipid length). The inset plot 
shows the correlation coefficient 
with the lipid score for differ-
ent thresholds ‘x’ in IPAx. The
legend shows the colour code 
for plaque types
 
Fig. 4 Colour coded IPA8.5 
embedded in an OCT L-mode 
image of an artery, showing 
high IPA at a site of plaque 
rupture. Colour scale runs from 
0 to 300; scale bars represent 
1 mm
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